Tolerogenic dendritic cells

Annual Review of Immunology

Volumn 21, Issue , 2003, Pages 685-711

  Steinman, Ralph M ^a   Hawiger, Daniel ^a   Nussenzweig, Michel C ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Antigen processing; DEC 205; Tolerance

Indexed keywords

CD205 ANTIBODY; CD205 ANTIGEN; CELL ANTIGEN; CELL RECEPTOR; CHEMOKINE; COLECALCIFEROL; CYSTEINE; FC RECEPTOR; GAMMA INTERFERON; GLYCOPROTEIN; INDOLEAMINE; INTEGRIN; INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2; LANGERIN; MACROPHAGE MANNOSE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE PROTEIN; OVALBUMIN; PROSTAGLANDIN E2; PROTEIN ANTIBODY; THIOREDOXIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; DEC 205 RECEPTOR; DEC-205 RECEPTOR; LECTIN; LEUKOCYTE ANTIGEN; MANNOSE BINDING LECTIN; MANNOSE RECEPTOR;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; AUTOIMMUNITY; CELL DEATH; CELL FUNCTION; CELL MATURATION; CONJUGATION; DENDRITIC CELL; EFFECTOR CELL; ENDOCYTOSIS; HUMAN; IMMUNE SYSTEM; IMMUNITY; IMMUNOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOID ORGAN; MEMORY CELL; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN TRANSPORT; REVIEW; STEADY STATE; T LYMPHOCYTE; THYMOCYTE; ANIMAL; BIOLOGICAL MODEL; CYTOLOGY; IMMUNOLOGY; METABOLISM; PANCREAS ISLET; REGULATORY T LYMPHOCYTE; THYMUS;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD; CLONAL DELETION; DENDRITIC CELLS; ENDOCYTOSIS; HUMANS; IMMUNE TOLERANCE; ISLETS OF LANGERHANS; LECTINS, C-TYPE; MANNOSE-BINDING LECTINS; MODELS, IMMUNOLOGICAL; RECEPTORS, CELL SURFACE; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND;

EID: 0042971652     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.21.120601.141040     Document Type: Review

References (177)

1. Guermonprez P, Valladeau J, Zitvogel L, Thery C, Amigorena S. 2002. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20:621-67
2. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, et al. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767-811
3. Lanzavecchia A, Sallusto F. 2001. The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. Curr. Opin. Immunol. 13:291-98
4. Pulendran B, Palucka K, Banchereau J. 2001. Sensing pathogens and tuning immune responses. Science 293:253-56
5. Liu YJ. 2001. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 106:259-62
6. Rescigno M, Borrow P. 2001. The host-pathogen interaction: new themes from dendritic cell biology. Cell 106:267-70
7. Reis e Sousa C, Hieny S, Scharton-Kersten T, Jankovic D, Charest H, et al. 1997. In vivo microbial stimulation induces rapid CD40L-independent production of IL-12 by dendritic cells and their re-distribution to T cell areas. J. Exp. Med. 186:1819-29
8. Dalod M, Salazar-Mather TP, Malmgaard L, Lewis C, Asselin-Paturel C, et al. 2002. Interferon α/β and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J. Exp. Med. 195:517-28
9. Fernandez NC, Lozier A, Flament C, Ricciardi-Castagnoli P, Bellet D, et al. 1999. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat. Med. 5:405-11
10. Fujii S, Shimizu K, Kronenberg M, Steinman RM 2002. Prolonged interferon-γ producing NKT response induced with α -galactosylceramide-loaded dendritic cells. Nat. Immunol. 3:867-74
11. Inaba K, Metlay JP, Crowley MT, Steinman RM. 1990. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J. Exp. Med. 172:631-40
12. Inaba K, Inaba M, Naito M, Steinman RM. 1993. Dendritic cell progenitors phagocytose particulates, including Bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J. Exp. Med. 178:479-88
13. Ludewig B, Ehl S, Karrer U, Odermatt B, Hengartner H, Zinkernagel RM. 1998. Dendritic cells efficiently induce protective antiviral immunity. J. Virol. 272:3812-18
14. Mayordomo JI, Zorina T, Storkus WJ, Zitvogel L, Celluzzi C, et al. 1995. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat. Med. 1:1297-302
15. - subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J. Exp. Med. 189:587-92
16. Schuler-Thurner B, Schultz ES, Berger TG, Weinlich G, Ebner S, et al. 2002. Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells. J. Exp. Med. 195:1279-88
17. Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, et al. 2002. Human epithelial cells trigger dendritic cell-mediated allergic inflammation by producing TSLP. Nat. Immunol. 3:673-80
18. Dhodapkar MV, Krasovsky J, Steinman RM, Bhardwaj N. 2000. Mature dendritic cells boost functionally superior T cells in humans without foreign helper epitopes. J. Clin. Invest. 105:R9-14
19. Kedl RM, Schaefer BC, Kappler JW, Marrack P. 2002. T cells down-modulate peptide-MHC complexes on APCs in vivo. Nat. Immunol. 3:27-32
20. De Smedt T, Pajak B, Muraille E, Lespagnard L, Heinen E, et al. 1996. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J. Exp. Med. 184:1413-24
21. Sparwasser T, Vabulas RM, Villmow B, Lipford GB, Wagner H. 2000. Bacterial CpG-DNA activates dendritic cells in vivo: T helper cell-independent cytotoxic T cell responses to soluble proteins. Eur. J. Immunol. 30:3591-97
22. Akbari O, Panjwani N, Garcia S, Tascon R, Lowrie D, Stockinger B. 1999. DNA vaccination: transfection and activation of dendritic cells as key events for immunity. J. Exp. Med. 189:169-78
23. Hawiger D, Inaba K, Dorsett Y, Guo K, Mahnke K, et al. K, 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194:769-80
24. + T cell tolerance. J. Exp. Med. 196:1627-38
25. Liu K, Iyoda T, Saternus M, Kimura Y, Inaba K, Steinman RM. 2002. Immune tolerance following delivery of dying cells to dendritic cells in situ. J. Exp. Med. 196: 1091-7
26. Sallusto F, Lanzavecchia A. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179:1109-18
27. Romani N, Reider D, Heuer M, Ebner S, Eibl B, et al. 1996. Generation of mature dendritic cells from human blood: an improved method with special regard to clinical applicability. J. Immunol. Methods 196:137-51
28. Bender A, Sapp M, Schuler G, Steinman RM, Bhardwaj N. 1996. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J. Immunol. Methods 196:121-35
29. Caux C, Massacrier C, Vanbervliet B, Dubois B, Van Kooten C, et al. 1994. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180:1263-72
30. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184:747-52
31. Koch F, Stanzl U, Jennewien P, Janke K, Heufler C, Kämpgen E, et al. 1996. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J. Exp. Med. 184:741-46
32. Inaba K, Turley S, Iyoda T, Yamaide F, Shimoyama S, et al. 2000. The formation of immunogenic MHC class II- peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli. J. Exp. Med. 191:927-36
33. Inaba K, Witmer-Pack M, Inaba M, Hathcock KS, Sakuta H, et al. 1994. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J. Exp. Med. 180:1849-60
34. Granucci F, Vizzardeili C, Pavelka N, Feau S, Persico M, et al. 2001. Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat. Immunol. 2:882-88
35. Angelini G, Gardella S, Ardy M, Ciriolo MR, Filomeni G, et al. 2002. Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation. Proc. Natl. Acad. Sci. USA 99:1491-96
36. Sallusto F, Palermo B, Lenig D, Miettinen M, Matikainen S, et al. 1999. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur. J. Immunol. 29:1617-25
37. Langenkamp A, Messi M, Lanzavecchia A, Sallusto F. 2000. Kinetics of dendritic cell activation: impact on priming of Th1, Th2 and nonpolarized T cells. Nat. Immunol. 1:311-16
38. Schuler G, Steinman RM. 1985. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J. Exp. Med. 161:526-46
39. Inaba K, Schuler G, Witmer MD, Valinsky J, Atassi B, Steinman RM. 1986. The immunologic properties of purified Langerhans cells: distinct requirements for the stimulation of unprimed and sensitized T lymphocytes. J. Exp. Med. 164:605-13
40. Menges M, Rossner S, Voigtlander C, Schindler H, Kukutsch NA, et al. 2002. Repetitive injections of dendritic cells matured with tumor necrosis factor α induce antigen-specific protection of mice from autoimmunity. J. Exp. Med. 195:15-22
41. Dhodapkar MV, Steinman RM, Krasovsky J, Munz C, Bhardwaj N. 2001. Antigen specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193:233-38
42. Legge KL, Gregg RK, Maldonado-Lopez R, Li L, Caprio JC, et al. 2002. On the role of dendritic cells in peripheral T cell tolerance and modulation of autoimmunity. J. Exp. Med. 196:217-27
43. Ferguson TA, Herndon J, Elzey B, Griffith TS, Schoenberger S, Green DR. 2002. Uptake of apoptotic antigen-coupled cells by lymphoid dendritic cells and cross-priming of CD8(+) T cells produce active immune unresponsiveness. J. Immunol. 168:5589-95
44. Schuurhuis DH, Laban S, Toes RE, Ricciardi-Castagnoli P, Kleijmeer MJ, et al. 2000. Immature dendritic cells acquire CD8(+) cytotoxic T lymphocyte priming capacity upon activation by T helper cell-independent or -dependent stimuli. J. Exp. Med. 192:145-50
45. Thurner B, Haendle I, Röder C, Dieckmann D, Keikavoussi P, et al. 1999. Vaccination with Mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J. Exp. Med. 190:1669-78
46. Schuler-Thurner B, Dieckmann D, Keikavoussi P, Bender A, Maczek C, et al. 2000. Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells. J. Immunol. 165:3492-96
47. Dhodapkar M, Steinman RM, Sapp M, Desai H, Fossella C, et al. 1999. Rapid generation of broad T-cell immunity in humans after single injection of mature dendritic cells. J. Clin. Invest. 104:173-80
48. Banchereau J, Palucka AK, Dhodapkar M, Burkeholder S, Taquet N, et al. 2001. Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine. Cancer Res. 61:6451-58
49. Kyburz D, Aichele P, Speiser DE, Hengartner H, Zinkernagel RM, Pircher H. 1993. T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides. Eur. J. Immunol. 23:1956-62
50. Aichele P, Kyburz D, Ohashi PS, Odermatt B, Zinkernagel RM, et al. 1994. Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model. Proc. Natl. Acad. Sci. USA 91:444-48
51. Kearney ER, Pape KA, Loh DY, Jenkins MK. 1994. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1:327-39
52. Liblau RS, Tisch R, Shokat K, Yang X-D, Dumont N, et al. 1996. Intravenous injection of soluble antigen induces thymic and peripheral T-cell apoptosis. Proc. Natl. Acad. Sci. USA 93:3031-36
53. Aichele P, Brduscha-Riem K, Zinkernagel RM, Hengartner H, Pircher H. 1995. T cell priming versus T cell tolerance induced by synthetic peptides. J. Exp. Med. 182:261-66
54. Sakaguchi S. 2000. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101:455-58
55. Heath WR, Carbone FR. 2001. Cross-presentation, dendritic cells, tolerance and immunity. Annu. Rev. Immunol. 19:47-64
56. Kamradt T, Mitchison NA. 2001. Tolerance and autoimmunity. N. Engl. J. Med. 344:655-64
57. Walker LSK, Abbas AK. 2002. The enemy within: keeping self-reactive T cells at bay in the periphery. Nat. Rev. Immunol. 2:11-19
58. Banchereau J, Steinman RM. 1998. Dendritic cells and the control of immunity. Nature 392:245-52
59. Billingham RE, Brent L, Medawar PB. 1953. Actively acquired tolerance of foreign cells. Nature 172:603-6
60. Matzinger P, Guerder S. 1989. Does T-cell tolerance require a dedicated antigen-presenting cell? Nature 338:74-76
61. Fairchild PJ, Austyn JM. 1990. Thymic dendritic cells: phenotype and function. Int. Rev. Immunol. 6:187-96
62. Zal T, Volkmann A, Stockinger B. 1994. Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen. J. Exp. Med. 180:2089-99
63. Volkmann A, Zal T, Stockinger B. 1997. Antigen-presenting cells in thymus that can negatively select MHC class II-restricted T cells recognizing a circulating self antigen. J. Immunol. 158:693-706
64. Brocker T, Riedinger M, Karjalainen K. 1997. Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J. Exp. Med. 185:541-50
65. Cosgrove D, Chan SH, Waltzinger C, Benoist C, Mathis D. 1992. The thymic compartment responsible for positive selection of CD4+ T cells. Int. Immunol. 4:707-10
66. Laufer TM, DeKoning J, Markowitz JS, Lo D, Glimcher LH. 1996. Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex. Nature 383:81-85
67. Laufer TM, Fan L, Glimcher LH. 1999. Self-reactive T cells selected on thymic cortical epithelium are polyclonal and are pathogenic in vivo. J. Immunol. 162:5078-84
68. Barclay AN, Mayrhofer G. 1981. Bone marrow origin of Ia-positive cells in the medulla of rat thymus. J. Exp. Med. 153:1666-71
69. Duncan SR, Capetanakis NG, Lawson BR, Theofilopoulos AN. 2002. Thymic dendritic cells traffic to thymi of allogeneic recipients and prolong graft survival. J. Clin. Invest. 109:755-64
70. Metlay JP, Witmer-Pack MD, Agger R, Crowley MT, Lawless D, Steinman RM. 1990. The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J. Exp. Med. 171:1753-71
71. Agger R, Witmer-Pack M, Romani N, Stössel H, Swiggard WJ, et al. 1992. Two populations of splenic dendritic cells detected with M342, a new monoclonal to an intracellular antigen of interdigitating dendritic cells and some B lymphocytes. J. Leukoc. Biol. 52:34-42
72. Hengartner H, Odermatt B, Schneider R, Schreyer M, Walle G, et al. 1988. Deletion of self-reative T cells before entry into the thymus medulla. Nature 336:388-90
73. a-encoded antigens. J. Exp. Med. 167:2005-10
74. Klein L, Klein T, Ruther U, Kyewski B. 1998. CD4 T cell tolerance to human c-reactive protein, an inducible serum protein, is mediated by medullary thymic epithelium. J. Exp. Med. 188:5-16
75. Kyewski B, Derbinski J, Gotter J, Klein L. 2002. Promiscuous gene expression and central T-cell tolerance: more than meets the eye. Trends Immunol. 23:364-71
76. Bouneaud C, Kourilsky P, Bousso P. 2000. Impact of negative selection on the T cell repertoire reactive to a self-peptide: a large fraction of T cell clones escapes clonal detection. Immunity 13:829-40
77. Rocha B, von Boehmer H. 1991. Peripheral selection of the T cell repertoire. Science 251:1225-28
78. Jones LA, Chin T, Longo DL, Kruisbeek AM. 1991. Peripheral clonal elimination of functional T cells. Science 250:1726-29
79. Albert ML, Pearce SFA, Francisco LM, Sauter B, Roy P, et al. 1998. Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 188:1359-68
80. Yrlid U, Wick MJ. 2000. Salmonella-induced apoptosis of infected macrophages results in presentation of a bacteria-encoded antigen after uptake by bystander dendritic cells. J. Exp. Med. 191:613-23
81. + T cells by dendritic cells. J. Virol. 74:10018-24
82. Berard F, Blanco P, Davoust J, Neidhart-Berard E-M, Nouri-Shirazi M, et al. 2000. Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells. J. Exp. Med. 192:1535-44
83. Dhodapkar KM, Krasovsky J, Williamson B, Dhodapkar MV. 2002. Anti-tumor monoclonal antibodies enhance cross-presentation of cellular antigens and the generation of myeloma-specific killer T cells by dendritic cells. J. Exp. Med. 195:125-33
84. Inaba K, Turley S, Yamaide F, Iyoda T, Mahnke K, et al. 1998. Efficient presentation of phagocytosed cellular fragments on the MHC class II products of dendritic cells. J. Exp. Med. 188:2163-73
85. + T cells after coculture with dead allogeneic cells. Hum. Immunol. 63:517-23
86. Munz C, Bickham KL, Subklewe M, Tsang ML, Chahroudi A, et al. 2000. Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1. J. Exp. Med. 191:1649-60
87. + killer T cells. J. Exp. Med. 193:405-12
88. Crowley M, Inaba K, Steinman RM. 1990. Dendritic cells are the principal cells in mouse spleen bearing immunogenic fragments of foreign proteins. J. Exp. Med. 172:383-86
89. Bujdoso R, Hopkins J, Dutia BM, Young P, McConnell I. 1989. Characterization of sheep afferent lymph dendritic cells and their role in antigen carriage. J. Exp. Med. 170:1285-302
90. Liu LM, MacPherson GG. 1993. Antigen acquisition by dendritic cells: intestinal dendritic cells acquire antigen administered orally and can prime naive T cells in vivo. J. Exp. Med. 177:1299-307
91. Holt PG, Schon-Hegrad MA, Oliver J. 1987. MHC class II antigen-bearing dendritic cells in pulmonary tissues of the rat. Regulation of antigen presentation activity by endogenous macrophage populations. J. Exp. Med. 167:262-74
92. Vermaelen KY, Carro-Muino I, Lambrecht BN, Pauwels RA. 2001. Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. J. Exp. Med. 193:51-60
93. Huang F-P, Platt N, Wykes M, Major JR, Powell TJ, et al. 2000. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med. 191:435-42
94. Scheinecker C, McHugh R, Shevach EM, Germain RN. 2002. Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J. Exp. Med. 196:1079-90
95. Steinman RM, Nussenzweig MC. 2002. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. USA 99:351-58
96. Steinman RM, Turley S, Mellman I, Inaba K. 2000. The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 191:411-16
97. Ezekowitz RAB, Sastry K, Bailly P, Warner A. 1990. Molecular characterization of the human macrophage mannose receptor: demonstration of multiple carbohydrate recognition-like domains and phagocytosis of yeasts in Cos-1 cells. J. Exp. Med. 172:1785-94
98. Taylor ME, Conary JT, Lennartz MR, Stahl PD, Drickamer K. 1990. Primary structure of the mannose receptor contains multiple motifs resembling carbohydrate-recognition domains. J. Biol. Chem. 265:12156-62
99. Swiggard WJ, Mirza A, Nussenzweig MC, Steinman RM. 1995. DEC-205, a 205 kDa protein abundant on mouse dendritic cells and thymic epithelium that is detected by the monoclonal antibody NLDC-145: purification, characterization and N-terminal amino acid sequence. Cell. Immunol. 165:302-11
100. Jiang W, Swiggard WJ, Heufler C, Peng M, Mirza A, et al. 1995. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 375:151-55
101. Stahl P, Schlesinger PH, Sigardson E, Rodman JS, Lee YC. 1980. Receptor-mediated pinocytosis of mannose glycoconjugates by macrophages: characterization and evidence for receptor recycling. Cell 19:207-15
102. Liu Y, Chirino AJ, Misulovin Z, Leteux C, Feizi T, et al. 2000. Crystal structure of the cysteine-rich domain of mannose receptor complexed with a sulfated carbohydrate ligand. J. Exp. Med. 191:1105-16
103. Lee SJ, Evers S, Roeder D, Parlow AF, Risteli J, et al. 2002. Mannose receptor-mediated regulation of serum glycoprotein homeostasis. Science 295:1898-901
104. Mahnke K, Guo M, Lee S, Sepulveda H, Swain SL, et al. 2000. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J. Cell Biol. 151:673-83
105. Sallusto F, Cella M, Danieli C, Lanzavecchia A. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate antigen in the major histocompatibility class II compartment. Downregulation by cytokines and bacterial products. J. Exp. Med. 182:389-400
106. Linehan SA, Martinez-Pomares L, Stahl PD, Gordon S. 1999. Mannose receptor and its putative ligands in normal murine lymphoid and nonlymphoid organs: in situ expression of mannose receptor by selected macrophages, endothelial cells, perivascular microglia, and mesangial cells, but not dendritic cells. J. Exp. Med. 189:1961-72
107. Guo M, Gong S, Maric S, Misulovin Z, Pack M, Mahnke K, et al. 2000. A monoclonal antibody to the DEC-205 endocytosis receptor on human dendritic cells. Hum. Immunol. 61:729-38
108. Kraal G, Breel M, Janse M, Bruin G. 1986. Langerhans cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody. J. Exp. Med. 163:981-97
109. Rodriguez A, Regnault A, Kleijmeer M, Ricciardi-Castagnoli P, Amigorena S. 1999. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat. Cell Biol. 1:362-68
110. Valladeau J, Ravel O, Dezutter-Dambuyant C, Moore K, Kleijmeer M, et al. 2000. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12:71-81
111. Valladeau J, Duvert-Frances V, Pin J-J, Kleijmeer MJ, Ait-Yahia S, et al. 2001. Immature human dendritic cells express asialoglycoprotein receptor isoforms for efficient receptor-mediated endocytosis. J. Immunol. 167:5767-74
112. Engering A, Geijtenbeek TB, van Vliet SJ, Wijers M, van Liempt E, et al. 2002. The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J. Immunol. 168:2118-26
113. Dzionek A, Sohma Y, Nagafune J, Cella M, Colonna M, et al. 2001. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen-capture and is a potent inhibitor of interferon-α/β induction. J. Exp. Med. 194:1823-34
114. Regnault A, Lankar D, Lacabanne V, Rodriguez A, Thery C, Rescigno M, et al. 1999. Fcγ receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J. Exp. Med. 189:371-80
115. Kalergis AM, Ravetch IV. 2002. Inducing tumor immunity through the selective engagement of activating Fcγ receptors on dendritic cells. J. Exp. Med. 195:1653-59
116. Rafiq K, Bergtold A, Clynes R. 2002. Immune complex-mediated antigen presentation induces tumor immunity. J. Clin. Invest. 110: 71-79
117. + cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells. J. Exp. Med. 195:113-23
118. Kurts C, Heath WR, Carbone FR, Allison J, Miller JFAP, Kosaka H. 1996. Constitutive class I-restricted exogenous presentation of self antigens in vivo. J. Exp. Med. 184:923-30
119. + T cells. J. Exp. Med. 186:239-45
120. + T cells undergoing peripheral deletion in response to cross-presentation of self-antigen. J. Exp. Med. 194:707-18
121. Hugues S, Mougneau E, Ferlin W, Jeske D, Hofman P, et al. 2002. Tolerance to islet antigens and prevention from diabetes induced by limited apoptosis of pancreatic β cells. Immunity 16:169-81
122. Kurts C, Cannarile M, Klebba I, Brocker T. 2001. Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo. J. Immunol. 166:1439-42
123. Crowley MT, Inaba K, Witmer-Pack MD, Gezelter S, Steinman RM. 1990. Use of the fluorescence activated cell sorter to enrich dendritic cells from mouse spleen. J. Immunol. Methods 133:55-66
124. + dendritic cell is responsible for inducing peripheral self tolerance to tissue-associated antigens. J. Exp. Med. 196:1099-104
125. Pugh CW, MacPherson GG, Steer HW. 1983. Characterization of nonlymphoid cells derived from rat peripheral lymph. J. Exp. Med. 157:1758-79
126. Okada CY, Rechsteiner M. 1982. Introduction of macromolecules into cultured mammalian cells by osmotic lysis of pinocytic vesicles. Cell 29:33-41
127. + dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J. Exp. Med. 195:1289-302
128. + dendritic cells is attributable to their ability to internalize dead cells. Immunology 107:183-89
129. + T cells and subsequently express CD8α and CD205 molecules. J. Exp. Med. 195:1233-45
130. + T cells by exogenous cell-associated antigens. Immunity. 17:211-20
131. Kreuwel HT, Aung S, Silao C, Sherman LA. 2002. Memory CD8(+) T cells undergo peripheral tolerance. Immunity 17:73-81
132. Mason D, Powrie F. 1998. Control of immune pathology by regulatory T cells. Curr. Opin. Immunol. 10:649-55
133. Roncarolo MG, Bacchetta R, Bordignon C, Narula S, Levings MK. 2001. Type 1 T regulatory cells. Immunol. Rev. 182:68-79
134. Shevach EM. 2000. Regulatory T cells in autoimmunity. Annu. Rev. Immunol. 18:423-49
135. Apostolou I, Sarukhan A, Klein L, Von Boehmer H. 2002. Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 3:756-63
136. +T suppressor cell clones produce TGF-β, but not IL-10, and are distinct from type 1 T regulatory cells. J. Exp. Med. 196:1335-46
137. + regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2:301-6
138. + immunoregulatory T cells. J. Exp. Med. 194:427-38
139. Bacchetta R, Bigler M, Touraine J-L, Parkman R, Tovo P-A, et al. 1994. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J. Exp. Med. 179:493-502
140. + immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99:3493-99
141. McGuirk P, McCann C, Mills KHG. 2002. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 195:221-31
142. + T regulatory cells suppress Helicobacter hepaticus-induced colitis. J. Exp. Med. 196:505-16
143. Randolph GJ, Beaulieu S, Steinman RM, Muller WA. 1998. Differentiation of monocytes into dendritic cells in a model that mimics entry of cells into afferent lymph. Science 282:480-83
144. Randolph GJ, Inaba K, Robbiani DF, Steinman RM, Muller WA. 1999. Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 11:753-61
145. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192:1213-22
146. Chang CC, Ciubotariu R, Manavalan JS, Yuan J, Colovai AI, et al. 2002. Nat. Immunol. 3:237-43
147. + regulatory T cells in vivo in humans. Blood 100:174-77
148. Akbari O, DeKruyff RH, Umetsu DT. 2001. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2:725-31
149. Akbari O, Freeman GJ, Meyer EH, Greenfield EA, Chang TT, et al. 2002. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med. 8:1024-32
150. Iwasaki A, Kelsall BL. 1999. Freshly isolated Peyer's Patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J. Exp. Med. 190:229-40
151. Buelens C, Verhasselt V, De Groote D, Thielemans K, Goldman M, Willems F. 1997. Interleukin-10 prevents the generation of dendritic cells from peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor. Eur. J. Immunol. 27:756-62
152. Bouloc A, Bagot M, Delaire S, Bensussan A, Boumsell L. 2000. Triggering CD101 molecule on human cutaneous dendritic cells inhibits T cell proliferation via IL-10 production. Eur. J. Immunol. 30:3132-39
153. Corinti S, Albanesi C, la Sala A, Pastore S, Girolomoni G. 2001. Regulatory activity of autocrine IL-10 on dendritic cell functions. J. Immunol. 166:4312-18
154. +) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195:603-16
155. Levings MK, Sangregorio R, Galbiati F, Squadrone S, de Waal Malefyt R, Roncarolo MG. 2001. IFN-α and IL-10 induce the differentiation of human type 1 T regulatory cells. J. Immunol. 166:5530-39
156. Bouillet P, Purton JF, Godfrey DI, Zhang LC, Coultas L, et al. 2002. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 415:922-26
157. Davey GM, Kurts C, Miller JFAP, Bouillet P, Strasser A, et al. 2002. Peripheral deletion of autoreactive CD8 T cells by cross-presentation of self antigen occurs by a Bcl-2-inhibitable pathway mediated by Bim. J. Exp. Med. 196: 947-55
158. + dendritic cells. Int. Immunol. 14:65-68
159. Munn DH, Sharma MD, Lee JR, Jhaver KG, Johnson TS, et al. 2002. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 297:1867-70
160. Hwu P, Du MX, Lapointe R, Do M, Taylor MW, Young HA. 2000. Indoleamine
161. + dendritic cells expressing indoleamine 2,3-dioxygenase. J. Immunol. 167:708-14
162. Terness P, Bauer TM, Rose L, Dufter C, Watzlik A, et al. 2002. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritc cells: mediation of suppression by tryptophan metabolites. J. Exp. Med. 196:447-57
163. Grohman U, Orabona C, Fallarino F, Vacca C, Calcinaro F, et al. 2002. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol. 3:1097-101
164. Geijtenbeek TBH, Torensma R, van Vliet SJ, van Duijnhoven GCF, Adema GJ, et al. 2000. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100:575-85
165. Malmström V, Shipton D, Singh B, Al-Shamkhani A, Puklavec MJ, et al. 2001. CD134L expression on dendritic cells in the mesenteric lymph nodes drives colitis in T cell-restored SCID mice. J. Immunol. 166:6972-81
166. Turley SJ, Inaba K, Garrett WS, Ebersold M, Untermaehrer J, et al. 2000. Transport of peptide-MHC class II complexes in developing dendritic cells. Science 288:522-27
167. Chow A, Toomre D, Garrett W, Mellman I. 2002. Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane. Nature 418:988-94
168. Boes M, Cerney J, Massol R, den Brouw MO, Kirchhausen T, et al. 2002. T-cell engagement of dendritic cells rapidly rearranges MHC class II transport. Nature 418:983-88
169. +) subset of human monocytes preferentially becomes migratory dendritic cells in a model tissue setting. J. Exp. Med. 196:517-27
170. Bychkov H, Verbovetski I, Trahtemberg U, Shapira I, Hareuveni M, et al. 2002. Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells and induces expression of CCR7 (EBI1) and migration to CCL19 (ECL/MIP-3β), but inhibits maturation. J. Exp. Med. 196:1553-61
171. Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J. 2001. Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus. Science 294:1540-43
172. Mehling A, Loser K, Varga G, Metze D, Luger TA, et al. 2001. Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity. J. Exp. Med. 194:615-28
173. Ohashi PS, Oehen S, Buerki K, Pitcher H, Ohashi CT, et al. 1991. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65:305-17
174. Oldstone M, Nerenberg M, Southern P, Price J, Lewicki H. 1991. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self [virus] immune response. Cell 65:319-31
175. Morgan DJ, Kreuwel HT, Sherman LA. 1999. Antigen concentration and precursor frequency determine the rate of CD8+ T cell tolerance to peripherally expressed antigens. J. Immunol. 163:723-27
176. Lechler R, Ng WF, Steinman RM. 2001. Dendritic cells in transplantation - friend or foe? Immunity 14:357-68
177. Dhodapkar MV, Krasovsky J, Olson K. 2002. T cells from the tumor microenvironment of patients with progressive myeloma can generate strong tumor specific cytolytic responses to autologous tumor-loaded dendritic cells. Proc. Natl. Acad. Sci. USA. 99:13009-12